EG628475 Activators
EG628475 Activators encompass a group of chemicals that are involved in modulating the activity of the protein kinase EG628475. These activators operate through a variety of mechanisms, primarily focusing on the regulation of cellular signaling pathways that EG628475 is part of, especially those that converge on the modulation of protein phosphorylation states. Many of these activators target the cAMP signaling cascade, a crucial pathway that regulates protein kinase A (PKA), which in turn can phosphorylate a wide array of substrates, potentially including EG628475. For instance, compounds such as Forskolin and IBMX work by increasing intracellular cAMP levels, either through direct stimulation of adenylyl cyclase or by inhibiting phosphodiesterases, the enzymes responsible for cAMP breakdown. This elevation in cAMP levels leads to the activation of PKA, which could then interact with and activate EG628475.
Additionally, certain EG628475 Activators affect the kinase activity through the modulation of related signaling molecules. Okadaic acid, for instance, inhibits protein phosphatases, which increases the overall phosphorylation levels in the cell that could enhance the activity of EG628475. Other compounds such as Anisomycin may activate the JNK pathway, leading to the generation of a cellular environment that fosters the activation of various kinases, including EG628475.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
A potent adenosine kinase inhibitor that increases intracellular adenosine, which can elevate cAMP levels through A2 receptors, potentially upregulating PKA and subsequent activation of EG628475. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, IBMX prevents the breakdown of cAMP, thus raising its levels within the cell and possibly enhancing PKA activity, which may indirectly activate EG628475. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective inhibitor of phosphodiesterase 4, Rolipram increases intracellular cAMP concentrations, which can promote PKA activation and might subsequently activate EG628475. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
Parathyroid hormone fragment that activates the PTH1 receptor and increases cAMP levels, possibly leading to the activation of PKA and subsequent activation of EG628475. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
An antibiotic that acts as a JNK activator by inducing the production of reactive oxygen species, which can affect various signaling pathways and may lead to the activation of EG628475. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell, which may indirectly enhance the activity of EG628475 if it is regulated by phosphorylation status. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol from green tea that can modulate various signaling pathways, including those related to kinase activation, and may influence the activity of EG628475 through these pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that directly activates cAMP-dependent pathways, potentially enhancing PKA activity and possibly leading to the activation of EG628475. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
A selective inhibitor of phosphodiesterase 5, Zaprinast increases cAMP levels in specific tissues, which may indirectly activate PKA and could result in the activation of EG628475. | ||||||